nodes	percent_of_prediction	percent_of_DWPC	metapath
Trabectedin—CYP2D6—Hydroxyurea—psoriasis	0.0591	0.0968	CbGbCtD
Trabectedin—CYP2C19—Cholecalciferol—psoriasis	0.0471	0.0772	CbGbCtD
Trabectedin—CYP3A4—Calcitriol—psoriasis	0.0442	0.0724	CbGbCtD
Trabectedin—CYP2C9—Cholecalciferol—psoriasis	0.0392	0.0642	CbGbCtD
Trabectedin—CYP2D6—Cholecalciferol—psoriasis	0.0358	0.0587	CbGbCtD
Trabectedin—CYP3A4—Methoxsalen—psoriasis	0.0344	0.0563	CbGbCtD
Trabectedin—CYP2C19—Prednisone—psoriasis	0.0327	0.0535	CbGbCtD
Trabectedin—CYP2E1—Dexamethasone—psoriasis	0.0325	0.0533	CbGbCtD
Trabectedin—CYP2C19—Cyclosporine—psoriasis	0.031	0.0507	CbGbCtD
Trabectedin—CYP2C9—Cyclosporine—psoriasis	0.0258	0.0422	CbGbCtD
Trabectedin—CYP2D6—Cyclosporine—psoriasis	0.0235	0.0386	CbGbCtD
Trabectedin—CYP3A4—Cholecalciferol—psoriasis	0.0228	0.0373	CbGbCtD
Trabectedin—CYP2C19—Dexamethasone—psoriasis	0.0204	0.0334	CbGbCtD
Trabectedin—CYP3A4—Mycophenolate mofetil—psoriasis	0.0198	0.0323	CbGbCtD
Trabectedin—CYP3A4—Triamcinolone—psoriasis	0.0198	0.0323	CbGbCtD
Trabectedin—CYP2C9—Dexamethasone—psoriasis	0.017	0.0278	CbGbCtD
Trabectedin—CYP3A4—Betamethasone—psoriasis	0.017	0.0278	CbGbCtD
Trabectedin—CYP3A4—Prednisolone—psoriasis	0.0167	0.0274	CbGbCtD
Trabectedin—CYP3A4—Hydrocortisone—psoriasis	0.0159	0.026	CbGbCtD
Trabectedin—CYP3A4—Prednisone—psoriasis	0.0158	0.0259	CbGbCtD
Trabectedin—CYP2D6—Dexamethasone—psoriasis	0.0155	0.0254	CbGbCtD
Trabectedin—CYP3A4—Cyclosporine—psoriasis	0.015	0.0245	CbGbCtD
Trabectedin—CYP3A4—Dexamethasone—psoriasis	0.00986	0.0161	CbGbCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—psoriasis	0.000247	0.000865	CcSEcCtD
Trabectedin—Syncope—Triamcinolone—psoriasis	0.000246	0.000864	CcSEcCtD
Trabectedin—Connective tissue disorder—Prednisone—psoriasis	0.000245	0.00086	CcSEcCtD
Trabectedin—Hypotension—Mycophenolate mofetil—psoriasis	0.000244	0.000857	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Cyclosporine—psoriasis	0.000244	0.000856	CcSEcCtD
Trabectedin—Oedema—Prednisolone—psoriasis	0.000244	0.000855	CcSEcCtD
Trabectedin—Neutropenia—Methotrexate—psoriasis	0.000243	0.000854	CcSEcCtD
Trabectedin—Insomnia—Cyclosporine—psoriasis	0.000242	0.00085	CcSEcCtD
Trabectedin—Loss of consciousness—Triamcinolone—psoriasis	0.000241	0.000847	CcSEcCtD
Trabectedin—Paraesthesia—Cyclosporine—psoriasis	0.000241	0.000844	CcSEcCtD
Trabectedin—Shock—Prednisolone—psoriasis	0.00024	0.000841	CcSEcCtD
Trabectedin—Cough—Triamcinolone—psoriasis	0.00024	0.000841	CcSEcCtD
Trabectedin—Dyspnoea—Cyclosporine—psoriasis	0.000239	0.000838	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Mycophenolate mofetil—psoriasis	0.000238	0.000835	CcSEcCtD
Trabectedin—Oedema—Hydrocortisone—psoriasis	0.000238	0.000835	CcSEcCtD
Trabectedin—Asthenia—Mycophenolic acid—psoriasis	0.000238	0.000833	CcSEcCtD
Trabectedin—Infection—Hydrocortisone—psoriasis	0.000237	0.00083	CcSEcCtD
Trabectedin—Insomnia—Mycophenolate mofetil—psoriasis	0.000236	0.000829	CcSEcCtD
Trabectedin—Dyspepsia—Cyclosporine—psoriasis	0.000236	0.000827	CcSEcCtD
Trabectedin—Nausea—Hydroxyurea—psoriasis	0.000235	0.000824	CcSEcCtD
Trabectedin—Paraesthesia—Mycophenolate mofetil—psoriasis	0.000235	0.000823	CcSEcCtD
Trabectedin—Shock—Hydrocortisone—psoriasis	0.000234	0.000822	CcSEcCtD
Trabectedin—Myalgia—Triamcinolone—psoriasis	0.000234	0.00082	CcSEcCtD
Trabectedin—Nervous system disorder—Hydrocortisone—psoriasis	0.000234	0.000819	CcSEcCtD
Trabectedin—Dyspnoea—Mycophenolate mofetil—psoriasis	0.000233	0.000817	CcSEcCtD
Trabectedin—Decreased appetite—Cyclosporine—psoriasis	0.000233	0.000817	CcSEcCtD
Trabectedin—Infestation NOS—Methotrexate—psoriasis	0.000232	0.000814	CcSEcCtD
Trabectedin—Infestation—Methotrexate—psoriasis	0.000232	0.000814	CcSEcCtD
Trabectedin—Flushing—Prednisone—psoriasis	0.000231	0.000812	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Cyclosporine—psoriasis	0.000231	0.000811	CcSEcCtD
Trabectedin—Skin disorder—Hydrocortisone—psoriasis	0.000231	0.000811	CcSEcCtD
Trabectedin—Fatigue—Cyclosporine—psoriasis	0.000231	0.00081	CcSEcCtD
Trabectedin—Dyspepsia—Mycophenolate mofetil—psoriasis	0.00023	0.000807	CcSEcCtD
Trabectedin—Constipation—Cyclosporine—psoriasis	0.000229	0.000804	CcSEcCtD
Trabectedin—Decreased appetite—Mycophenolate mofetil—psoriasis	0.000227	0.000797	CcSEcCtD
Trabectedin—Anorexia—Hydrocortisone—psoriasis	0.000227	0.000796	CcSEcCtD
Trabectedin—Diarrhoea—Mycophenolic acid—psoriasis	0.000227	0.000795	CcSEcCtD
Trabectedin—Stomatitis—Methotrexate—psoriasis	0.000226	0.000794	CcSEcCtD
Trabectedin—Angiopathy—Prednisone—psoriasis	0.000226	0.000794	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	0.000226	0.000792	CcSEcCtD
Trabectedin—Oedema—Triamcinolone—psoriasis	0.000224	0.000786	CcSEcCtD
Trabectedin—Syncope—Betamethasone—psoriasis	0.000224	0.000784	CcSEcCtD
Trabectedin—Syncope—Dexamethasone—psoriasis	0.000224	0.000784	CcSEcCtD
Trabectedin—Constipation—Mycophenolate mofetil—psoriasis	0.000224	0.000784	CcSEcCtD
Trabectedin—Infection—Triamcinolone—psoriasis	0.000223	0.000781	CcSEcCtD
Trabectedin—Hypotension—Hydrocortisone—psoriasis	0.000222	0.00078	CcSEcCtD
Trabectedin—Shock—Triamcinolone—psoriasis	0.000221	0.000774	CcSEcCtD
Trabectedin—Insomnia—Prednisolone—psoriasis	0.000221	0.000774	CcSEcCtD
Trabectedin—Alopecia—Prednisone—psoriasis	0.00022	0.000773	CcSEcCtD
Trabectedin—Hepatobiliary disease—Methotrexate—psoriasis	0.00022	0.00077	CcSEcCtD
Trabectedin—Gastrointestinal pain—Cyclosporine—psoriasis	0.000219	0.000769	CcSEcCtD
Trabectedin—Loss of consciousness—Dexamethasone—psoriasis	0.000219	0.000768	CcSEcCtD
Trabectedin—Loss of consciousness—Betamethasone—psoriasis	0.000219	0.000768	CcSEcCtD
Trabectedin—Dizziness—Mycophenolic acid—psoriasis	0.000219	0.000768	CcSEcCtD
Trabectedin—Paraesthesia—Prednisolone—psoriasis	0.000219	0.000768	CcSEcCtD
Trabectedin—Mental disorder—Prednisone—psoriasis	0.000218	0.000766	CcSEcCtD
Trabectedin—Malnutrition—Prednisone—psoriasis	0.000217	0.000761	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Hydrocortisone—psoriasis	0.000217	0.000761	CcSEcCtD
Trabectedin—Agranulocytosis—Methotrexate—psoriasis	0.000217	0.00076	CcSEcCtD
Trabectedin—Insomnia—Hydrocortisone—psoriasis	0.000215	0.000755	CcSEcCtD
Trabectedin—Paraesthesia—Hydrocortisone—psoriasis	0.000214	0.00075	CcSEcCtD
Trabectedin—Gastrointestinal pain—Mycophenolate mofetil—psoriasis	0.000214	0.00075	CcSEcCtD
Trabectedin—Myalgia—Dexamethasone—psoriasis	0.000212	0.000744	CcSEcCtD
Trabectedin—Myalgia—Betamethasone—psoriasis	0.000212	0.000744	CcSEcCtD
Trabectedin—Body temperature increased—Cyclosporine—psoriasis	0.000212	0.000743	CcSEcCtD
Trabectedin—Abdominal pain—Cyclosporine—psoriasis	0.000212	0.000743	CcSEcCtD
Trabectedin—Vomiting—Mycophenolic acid—psoriasis	0.000211	0.000739	CcSEcCtD
Trabectedin—Dyspepsia—Hydrocortisone—psoriasis	0.00021	0.000735	CcSEcCtD
Trabectedin—Haemoglobin—Methotrexate—psoriasis	0.000209	0.000735	CcSEcCtD
Trabectedin—CYP2C19—Melatonin metabolism and effects—NFKB1—psoriasis	0.000209	0.00201	CbGpPWpGaD
Trabectedin—Rash—Mycophenolic acid—psoriasis	0.000209	0.000732	CcSEcCtD
Trabectedin—Dermatitis—Mycophenolic acid—psoriasis	0.000209	0.000732	CcSEcCtD
Trabectedin—Haemorrhage—Methotrexate—psoriasis	0.000208	0.000731	CcSEcCtD
Trabectedin—Headache—Mycophenolic acid—psoriasis	0.000207	0.000728	CcSEcCtD
Trabectedin—SRC—RANKL/RANK Signaling Pathway—NFKB1—psoriasis	0.000207	0.00199	CbGpPWpGaD
Trabectedin—Decreased appetite—Hydrocortisone—psoriasis	0.000207	0.000726	CcSEcCtD
Trabectedin—Body temperature increased—Mycophenolate mofetil—psoriasis	0.000207	0.000725	CcSEcCtD
Trabectedin—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000207	0.000725	CcSEcCtD
Trabectedin—SRC—Immune System—KIR2DS1—psoriasis	0.000206	0.00198	CbGpPWpGaD
Trabectedin—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.000206	0.000721	CcSEcCtD
Trabectedin—Fatigue—Hydrocortisone—psoriasis	0.000205	0.00072	CcSEcCtD
Trabectedin—SRC—LPA receptor mediated events—CXCL8—psoriasis	0.000205	0.00197	CbGpPWpGaD
Trabectedin—Musculoskeletal discomfort—Triamcinolone—psoriasis	0.000204	0.000717	CcSEcCtD
Trabectedin—SRC—IL-3 Signaling Pathway—STAT3—psoriasis	0.000204	0.00196	CbGpPWpGaD
Trabectedin—Oedema—Dexamethasone—psoriasis	0.000203	0.000714	CcSEcCtD
Trabectedin—Oedema—Betamethasone—psoriasis	0.000203	0.000714	CcSEcCtD
Trabectedin—SRC—Costimulation by the CD28 family—CD4—psoriasis	0.000203	0.00195	CbGpPWpGaD
Trabectedin—Insomnia—Triamcinolone—psoriasis	0.000203	0.000711	CcSEcCtD
Trabectedin—Infection—Dexamethasone—psoriasis	0.000202	0.000709	CcSEcCtD
Trabectedin—Infection—Betamethasone—psoriasis	0.000202	0.000709	CcSEcCtD
Trabectedin—Paraesthesia—Triamcinolone—psoriasis	0.000201	0.000706	CcSEcCtD
Trabectedin—Anaemia—Prednisone—psoriasis	0.000201	0.000704	CcSEcCtD
Trabectedin—Shock—Dexamethasone—psoriasis	0.0002	0.000702	CcSEcCtD
Trabectedin—Shock—Betamethasone—psoriasis	0.0002	0.000702	CcSEcCtD
Trabectedin—Dyspnoea—Triamcinolone—psoriasis	0.0002	0.000701	CcSEcCtD
Trabectedin—Nervous system disorder—Dexamethasone—psoriasis	0.0002	0.0007	CcSEcCtD
Trabectedin—Nervous system disorder—Betamethasone—psoriasis	0.0002	0.0007	CcSEcCtD
Trabectedin—Thrombocytopenia—Betamethasone—psoriasis	0.000199	0.000699	CcSEcCtD
Trabectedin—Thrombocytopenia—Dexamethasone—psoriasis	0.000199	0.000699	CcSEcCtD
Trabectedin—SRC—Signaling events mediated by focal adhesion kinase—JUN—psoriasis	0.000198	0.0019	CbGpPWpGaD
Trabectedin—Hypersensitivity—Cyclosporine—psoriasis	0.000197	0.000692	CcSEcCtD
Trabectedin—Dyspepsia—Triamcinolone—psoriasis	0.000197	0.000692	CcSEcCtD
Trabectedin—Nausea—Mycophenolic acid—psoriasis	0.000197	0.00069	CcSEcCtD
Trabectedin—Gastrointestinal pain—Hydrocortisone—psoriasis	0.000195	0.000683	CcSEcCtD
Trabectedin—Syncope—Prednisone—psoriasis	0.000195	0.000683	CcSEcCtD
Trabectedin—SRC—Signaling events mediated by PTP1B—STAT3—psoriasis	0.000195	0.00187	CbGpPWpGaD
Trabectedin—Anorexia—Dexamethasone—psoriasis	0.000194	0.00068	CcSEcCtD
Trabectedin—Anorexia—Betamethasone—psoriasis	0.000194	0.00068	CcSEcCtD
Trabectedin—Fatigue—Triamcinolone—psoriasis	0.000193	0.000678	CcSEcCtD
Trabectedin—SRC—Endothelins—JUN—psoriasis	0.000193	0.00185	CbGpPWpGaD
Trabectedin—CYP2D6—Melatonin metabolism and effects—NFKB1—psoriasis	0.000193	0.00185	CbGpPWpGaD
Trabectedin—Hypersensitivity—Mycophenolate mofetil—psoriasis	0.000193	0.000675	CcSEcCtD
Trabectedin—Asthenia—Cyclosporine—psoriasis	0.000192	0.000674	CcSEcCtD
Trabectedin—SRC—Signalling to RAS—IL6—psoriasis	0.000191	0.00183	CbGpPWpGaD
Trabectedin—SRC—VEGFR2 mediated cell proliferation—IL6—psoriasis	0.000191	0.00183	CbGpPWpGaD
Trabectedin—Loss of consciousness—Prednisone—psoriasis	0.000191	0.000669	CcSEcCtD
Trabectedin—SRC—Notch Signaling Pathway—NFKB1—psoriasis	0.000191	0.00183	CbGpPWpGaD
Trabectedin—SRC—LPA receptor mediated events—JUN—psoriasis	0.000191	0.00183	CbGpPWpGaD
Trabectedin—Hypotension—Dexamethasone—psoriasis	0.00019	0.000667	CcSEcCtD
Trabectedin—Hypotension—Betamethasone—psoriasis	0.00019	0.000667	CcSEcCtD
Trabectedin—Angiopathy—Methotrexate—psoriasis	0.000189	0.000663	CcSEcCtD
Trabectedin—SRC—FGF signaling pathway—STAT3—psoriasis	0.000189	0.00181	CbGpPWpGaD
Trabectedin—CYP3A4—Tryptophan metabolism—CAT—psoriasis	0.000188	0.00181	CbGpPWpGaD
Trabectedin—Abdominal pain—Hydrocortisone—psoriasis	0.000188	0.00066	CcSEcCtD
Trabectedin—Body temperature increased—Hydrocortisone—psoriasis	0.000188	0.00066	CcSEcCtD
Trabectedin—Mediastinal disorder—Methotrexate—psoriasis	0.000188	0.000659	CcSEcCtD
Trabectedin—Asthenia—Mycophenolate mofetil—psoriasis	0.000188	0.000658	CcSEcCtD
Trabectedin—SRC—AGE/RAGE pathway—JUN—psoriasis	0.000186	0.00179	CbGpPWpGaD
Trabectedin—SRC—TSH signaling pathway—JUN—psoriasis	0.000186	0.00179	CbGpPWpGaD
Trabectedin—SRC—Aryl Hydrocarbon Receptor—TNF—psoriasis	0.000186	0.00178	CbGpPWpGaD
Trabectedin—SRC—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	0.000186	0.00178	CbGpPWpGaD
Trabectedin—Musculoskeletal discomfort—Betamethasone—psoriasis	0.000185	0.00065	CcSEcCtD
Trabectedin—Musculoskeletal discomfort—Dexamethasone—psoriasis	0.000185	0.00065	CcSEcCtD
Trabectedin—Myalgia—Prednisone—psoriasis	0.000185	0.000648	CcSEcCtD
Trabectedin—Arthralgia—Prednisone—psoriasis	0.000185	0.000648	CcSEcCtD
Trabectedin—Alopecia—Methotrexate—psoriasis	0.000184	0.000646	CcSEcCtD
Trabectedin—Insomnia—Betamethasone—psoriasis	0.000184	0.000645	CcSEcCtD
Trabectedin—Insomnia—Dexamethasone—psoriasis	0.000184	0.000645	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriasis	0.000184	0.000644	CcSEcCtD
Trabectedin—SRC—LPA receptor mediated events—NFKB1—psoriasis	0.000183	0.00176	CbGpPWpGaD
Trabectedin—Diarrhoea—Cyclosporine—psoriasis	0.000183	0.000643	CcSEcCtD
Trabectedin—Paraesthesia—Betamethasone—psoriasis	0.000183	0.000641	CcSEcCtD
Trabectedin—Paraesthesia—Dexamethasone—psoriasis	0.000183	0.000641	CcSEcCtD
Trabectedin—Mental disorder—Methotrexate—psoriasis	0.000183	0.00064	CcSEcCtD
Trabectedin—Malnutrition—Methotrexate—psoriasis	0.000181	0.000636	CcSEcCtD
Trabectedin—SRC—Oncostatin M Signaling Pathway—NFKB1—psoriasis	0.000181	0.00174	CbGpPWpGaD
Trabectedin—PTGS1—Selenium Micronutrient Network—IFNG—psoriasis	0.00018	0.00173	CbGpPWpGaD
Trabectedin—Hypersensitivity—Prednisolone—psoriasis	0.00018	0.00063	CcSEcCtD
Trabectedin—Dyspepsia—Betamethasone—psoriasis	0.000179	0.000628	CcSEcCtD
Trabectedin—Dyspepsia—Dexamethasone—psoriasis	0.000179	0.000628	CcSEcCtD
Trabectedin—SRC—AGE/RAGE pathway—NFKB1—psoriasis	0.000179	0.00172	CbGpPWpGaD
Trabectedin—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000179	0.000627	CcSEcCtD
Trabectedin—Dysgeusia—Methotrexate—psoriasis	0.000178	0.000623	CcSEcCtD
Trabectedin—SRC—CDC42 signaling events—JUN—psoriasis	0.000177	0.0017	CbGpPWpGaD
Trabectedin—Body temperature increased—Triamcinolone—psoriasis	0.000177	0.000622	CcSEcCtD
Trabectedin—Dizziness—Cyclosporine—psoriasis	0.000177	0.000621	CcSEcCtD
Trabectedin—Oedema—Prednisone—psoriasis	0.000177	0.000621	CcSEcCtD
Trabectedin—Decreased appetite—Dexamethasone—psoriasis	0.000177	0.00062	CcSEcCtD
Trabectedin—Decreased appetite—Betamethasone—psoriasis	0.000177	0.00062	CcSEcCtD
Trabectedin—SRC—Rac1/Pak1/p38/MMP-2 pathway—NFKB1—psoriasis	0.000177	0.0017	CbGpPWpGaD
Trabectedin—Infection—Prednisone—psoriasis	0.000176	0.000617	CcSEcCtD
Trabectedin—SRC—Kit receptor signaling pathway—STAT3—psoriasis	0.000176	0.00169	CbGpPWpGaD
Trabectedin—Gastrointestinal disorder—Dexamethasone—psoriasis	0.000176	0.000616	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Betamethasone—psoriasis	0.000176	0.000616	CcSEcCtD
Trabectedin—Back pain—Methotrexate—psoriasis	0.000175	0.000616	CcSEcCtD
Trabectedin—Hypersensitivity—Hydrocortisone—psoriasis	0.000175	0.000615	CcSEcCtD
Trabectedin—Fatigue—Dexamethasone—psoriasis	0.000175	0.000615	CcSEcCtD
Trabectedin—Fatigue—Betamethasone—psoriasis	0.000175	0.000615	CcSEcCtD
Trabectedin—Shock—Prednisone—psoriasis	0.000174	0.000611	CcSEcCtD
Trabectedin—Nervous system disorder—Prednisone—psoriasis	0.000174	0.000609	CcSEcCtD
Trabectedin—SRC—Adaptive Immune System—ERAP1—psoriasis	0.000174	0.00167	CbGpPWpGaD
Trabectedin—Dizziness—Mycophenolate mofetil—psoriasis	0.000173	0.000606	CcSEcCtD
Trabectedin—Skin disorder—Prednisone—psoriasis	0.000172	0.000604	CcSEcCtD
Trabectedin—SRC—Notch Signaling Pathway—STAT3—psoriasis	0.000171	0.00165	CbGpPWpGaD
Trabectedin—SRC—CXCR4-mediated signaling events—CD4—psoriasis	0.000171	0.00165	CbGpPWpGaD
Trabectedin—Asthenia—Hydrocortisone—psoriasis	0.000171	0.000599	CcSEcCtD
Trabectedin—Vomiting—Cyclosporine—psoriasis	0.00017	0.000598	CcSEcCtD
Trabectedin—Rash—Cyclosporine—psoriasis	0.000169	0.000593	CcSEcCtD
Trabectedin—Anorexia—Prednisone—psoriasis	0.000169	0.000592	CcSEcCtD
Trabectedin—Dermatitis—Cyclosporine—psoriasis	0.000169	0.000592	CcSEcCtD
Trabectedin—SRC—Integrins in angiogenesis—VEGFA—psoriasis	0.000169	0.00162	CbGpPWpGaD
Trabectedin—Headache—Cyclosporine—psoriasis	0.000168	0.000589	CcSEcCtD
Trabectedin—Anaemia—Methotrexate—psoriasis	0.000168	0.000588	CcSEcCtD
Trabectedin—Gastrointestinal pain—Dexamethasone—psoriasis	0.000166	0.000584	CcSEcCtD
Trabectedin—Gastrointestinal pain—Betamethasone—psoriasis	0.000166	0.000584	CcSEcCtD
Trabectedin—Vomiting—Mycophenolate mofetil—psoriasis	0.000166	0.000583	CcSEcCtD
Trabectedin—Hypersensitivity—Triamcinolone—psoriasis	0.000165	0.000579	CcSEcCtD
Trabectedin—Rash—Mycophenolate mofetil—psoriasis	0.000165	0.000578	CcSEcCtD
Trabectedin—Dermatitis—Mycophenolate mofetil—psoriasis	0.000165	0.000578	CcSEcCtD
Trabectedin—SRC—Oncostatin M Signaling Pathway—VEGFA—psoriasis	0.000164	0.00158	CbGpPWpGaD
Trabectedin—Headache—Mycophenolate mofetil—psoriasis	0.000164	0.000574	CcSEcCtD
Trabectedin—Diarrhoea—Hydrocortisone—psoriasis	0.000163	0.000571	CcSEcCtD
Trabectedin—SRC—Oncostatin M Signaling Pathway—STAT3—psoriasis	0.000163	0.00156	CbGpPWpGaD
Trabectedin—SRC—EGF/EGFR Signaling Pathway—PCNA—psoriasis	0.000163	0.00156	CbGpPWpGaD
Trabectedin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	0.000162	0.00156	CbGpPWpGaD
Trabectedin—Leukopenia—Methotrexate—psoriasis	0.000162	0.00057	CcSEcCtD
Trabectedin—SRC—Leptin signaling pathway—NFKB1—psoriasis	0.000162	0.00155	CbGpPWpGaD
Trabectedin—Musculoskeletal discomfort—Prednisone—psoriasis	0.000161	0.000566	CcSEcCtD
Trabectedin—Dizziness—Prednisolone—psoriasis	0.000161	0.000566	CcSEcCtD
Trabectedin—Asthenia—Triamcinolone—psoriasis	0.000161	0.000564	CcSEcCtD
Trabectedin—SRC—AGE/RAGE pathway—STAT3—psoriasis	0.000161	0.00154	CbGpPWpGaD
Trabectedin—SRC—TSH signaling pathway—STAT3—psoriasis	0.000161	0.00154	CbGpPWpGaD
Trabectedin—Body temperature increased—Dexamethasone—psoriasis	0.000161	0.000564	CcSEcCtD
Trabectedin—Abdominal pain—Betamethasone—psoriasis	0.000161	0.000564	CcSEcCtD
Trabectedin—Abdominal pain—Dexamethasone—psoriasis	0.000161	0.000564	CcSEcCtD
Trabectedin—Body temperature increased—Betamethasone—psoriasis	0.000161	0.000564	CcSEcCtD
Trabectedin—Insomnia—Prednisone—psoriasis	0.00016	0.000562	CcSEcCtD
Trabectedin—SRC—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—JUN—psoriasis	0.000159	0.00153	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—DDX58—psoriasis	0.000159	0.00153	CbGpPWpGaD
Trabectedin—Nausea—Cyclosporine—psoriasis	0.000159	0.000558	CcSEcCtD
Trabectedin—Paraesthesia—Prednisone—psoriasis	0.000159	0.000558	CcSEcCtD
Trabectedin—SRC—Rac1/Pak1/p38/MMP-2 pathway—STAT3—psoriasis	0.000159	0.00153	CbGpPWpGaD
Trabectedin—SRC—Signaling events mediated by VEGFR1 and VEGFR2—VEGFA—psoriasis	0.000159	0.00152	CbGpPWpGaD
Trabectedin—Cough—Methotrexate—psoriasis	0.000158	0.000555	CcSEcCtD
Trabectedin—Dizziness—Hydrocortisone—psoriasis	0.000157	0.000552	CcSEcCtD
Trabectedin—SRC—VEGFA-VEGFR2 Pathway—TYK2—psoriasis	0.000156	0.0015	CbGpPWpGaD
Trabectedin—Dyspepsia—Prednisone—psoriasis	0.000156	0.000547	CcSEcCtD
Trabectedin—SRC—Signalling to ERKs—IL6—psoriasis	0.000155	0.00149	CbGpPWpGaD
Trabectedin—Nausea—Mycophenolate mofetil—psoriasis	0.000155	0.000545	CcSEcCtD
Trabectedin—Myalgia—Methotrexate—psoriasis	0.000154	0.000542	CcSEcCtD
Trabectedin—Arthralgia—Methotrexate—psoriasis	0.000154	0.000542	CcSEcCtD
Trabectedin—Decreased appetite—Prednisone—psoriasis	0.000154	0.00054	CcSEcCtD
Trabectedin—Rash—Prednisolone—psoriasis	0.000154	0.000539	CcSEcCtD
Trabectedin—Dermatitis—Prednisolone—psoriasis	0.000154	0.000539	CcSEcCtD
Trabectedin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriasis	0.000153	0.000538	CcSEcCtD
Trabectedin—Fatigue—Prednisone—psoriasis	0.000153	0.000536	CcSEcCtD
Trabectedin—Headache—Prednisolone—psoriasis	0.000153	0.000536	CcSEcCtD
Trabectedin—Constipation—Prednisone—psoriasis	0.000152	0.000531	CcSEcCtD
Trabectedin—Vomiting—Hydrocortisone—psoriasis	0.000151	0.000531	CcSEcCtD
Trabectedin—SRC—BDNF signaling pathway—NFKBIA—psoriasis	0.00015	0.00144	CbGpPWpGaD
Trabectedin—Rash—Hydrocortisone—psoriasis	0.00015	0.000527	CcSEcCtD
Trabectedin—Dermatitis—Hydrocortisone—psoriasis	0.00015	0.000526	CcSEcCtD
Trabectedin—PTGS1—Selenium Micronutrient Network—NFKB1—psoriasis	0.000149	0.00144	CbGpPWpGaD
Trabectedin—Headache—Hydrocortisone—psoriasis	0.000149	0.000523	CcSEcCtD
Trabectedin—SRC—Senescence and Autophagy in Cancer—IFNG—psoriasis	0.000148	0.00143	CbGpPWpGaD
Trabectedin—Dizziness—Triamcinolone—psoriasis	0.000148	0.00052	CcSEcCtD
Trabectedin—SRC—TSLP Signaling Pathway—IL6—psoriasis	0.000147	0.00142	CbGpPWpGaD
Trabectedin—SRC—Signaling by VEGF—TYK2—psoriasis	0.000147	0.00141	CbGpPWpGaD
Trabectedin—Infection—Methotrexate—psoriasis	0.000147	0.000516	CcSEcCtD
Trabectedin—SRC—Androgen receptor signaling pathway—JUN—psoriasis	0.000146	0.00141	CbGpPWpGaD
Trabectedin—Asthenia—Betamethasone—psoriasis	0.000146	0.000512	CcSEcCtD
Trabectedin—Asthenia—Dexamethasone—psoriasis	0.000146	0.000512	CcSEcCtD
Trabectedin—Nervous system disorder—Methotrexate—psoriasis	0.000145	0.000509	CcSEcCtD
Trabectedin—SRC—Leptin signaling pathway—STAT3—psoriasis	0.000145	0.00139	CbGpPWpGaD
Trabectedin—Thrombocytopenia—Methotrexate—psoriasis	0.000145	0.000509	CcSEcCtD
Trabectedin—Gastrointestinal pain—Prednisone—psoriasis	0.000145	0.000508	CcSEcCtD
Trabectedin—Nausea—Prednisolone—psoriasis	0.000145	0.000508	CcSEcCtD
Trabectedin—SRC—ErbB Signaling Pathway—TP53—psoriasis	0.000144	0.00138	CbGpPWpGaD
Trabectedin—Skin disorder—Methotrexate—psoriasis	0.000144	0.000504	CcSEcCtD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—PCNA—psoriasis	0.000143	0.00137	CbGpPWpGaD
Trabectedin—Vomiting—Triamcinolone—psoriasis	0.000143	0.0005	CcSEcCtD
Trabectedin—Nausea—Hydrocortisone—psoriasis	0.000141	0.000496	CcSEcCtD
Trabectedin—Rash—Triamcinolone—psoriasis	0.000141	0.000496	CcSEcCtD
Trabectedin—Dermatitis—Triamcinolone—psoriasis	0.000141	0.000495	CcSEcCtD
Trabectedin—Anorexia—Methotrexate—psoriasis	0.000141	0.000495	CcSEcCtD
Trabectedin—Headache—Triamcinolone—psoriasis	0.00014	0.000493	CcSEcCtD
Trabectedin—Body temperature increased—Prednisone—psoriasis	0.00014	0.000491	CcSEcCtD
Trabectedin—Abdominal pain—Prednisone—psoriasis	0.00014	0.000491	CcSEcCtD
Trabectedin—Diarrhoea—Dexamethasone—psoriasis	0.000139	0.000488	CcSEcCtD
Trabectedin—Diarrhoea—Betamethasone—psoriasis	0.000139	0.000488	CcSEcCtD
Trabectedin—Hypotension—Methotrexate—psoriasis	0.000138	0.000485	CcSEcCtD
Trabectedin—SRC—Senescence and Autophagy in Cancer—CXCL8—psoriasis	0.000138	0.00133	CbGpPWpGaD
Trabectedin—Musculoskeletal discomfort—Methotrexate—psoriasis	0.000135	0.000473	CcSEcCtD
Trabectedin—Dizziness—Betamethasone—psoriasis	0.000135	0.000472	CcSEcCtD
Trabectedin—Dizziness—Dexamethasone—psoriasis	0.000135	0.000472	CcSEcCtD
Trabectedin—SRC—Hemostasis—ITGAL—psoriasis	0.000134	0.00129	CbGpPWpGaD
Trabectedin—Insomnia—Methotrexate—psoriasis	0.000134	0.00047	CcSEcCtD
Trabectedin—Nausea—Triamcinolone—psoriasis	0.000133	0.000467	CcSEcCtD
Trabectedin—Paraesthesia—Methotrexate—psoriasis	0.000133	0.000466	CcSEcCtD
Trabectedin—SRC—CXCR4-mediated signaling events—STAT3—psoriasis	0.000133	0.00127	CbGpPWpGaD
Trabectedin—Dyspnoea—Methotrexate—psoriasis	0.000132	0.000463	CcSEcCtD
Trabectedin—Hypersensitivity—Prednisone—psoriasis	0.000131	0.000458	CcSEcCtD
Trabectedin—Dyspepsia—Methotrexate—psoriasis	0.00013	0.000457	CcSEcCtD
Trabectedin—Vomiting—Dexamethasone—psoriasis	0.000129	0.000454	CcSEcCtD
Trabectedin—Vomiting—Betamethasone—psoriasis	0.000129	0.000454	CcSEcCtD
Trabectedin—Decreased appetite—Methotrexate—psoriasis	0.000129	0.000451	CcSEcCtD
Trabectedin—Rash—Betamethasone—psoriasis	0.000128	0.00045	CcSEcCtD
Trabectedin—Rash—Dexamethasone—psoriasis	0.000128	0.00045	CcSEcCtD
Trabectedin—SRC—Senescence and Autophagy in Cancer—JUN—psoriasis	0.000128	0.00123	CbGpPWpGaD
Trabectedin—SRC—ErbB1 downstream signaling—JUN—psoriasis	0.000128	0.00123	CbGpPWpGaD
Trabectedin—Dermatitis—Dexamethasone—psoriasis	0.000128	0.00045	CcSEcCtD
Trabectedin—Dermatitis—Betamethasone—psoriasis	0.000128	0.00045	CcSEcCtD
Trabectedin—Gastrointestinal disorder—Methotrexate—psoriasis	0.000128	0.000448	CcSEcCtD
Trabectedin—Fatigue—Methotrexate—psoriasis	0.000128	0.000448	CcSEcCtD
Trabectedin—Headache—Dexamethasone—psoriasis	0.000127	0.000447	CcSEcCtD
Trabectedin—Headache—Betamethasone—psoriasis	0.000127	0.000447	CcSEcCtD
Trabectedin—Asthenia—Prednisone—psoriasis	0.000127	0.000446	CcSEcCtD
Trabectedin—PTGS1—Metabolism—NDUFA5—psoriasis	0.000127	0.00122	CbGpPWpGaD
Trabectedin—SRC—Androgen receptor signaling pathway—STAT3—psoriasis	0.000127	0.00122	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—CARM1—psoriasis	0.000126	0.00121	CbGpPWpGaD
Trabectedin—SRC—Signaling by SCF-KIT—TYK2—psoriasis	0.000125	0.0012	CbGpPWpGaD
Trabectedin—SRC—Oncostatin M Signaling Pathway—TP53—psoriasis	0.000124	0.00119	CbGpPWpGaD
Trabectedin—SRC—EPH-Ephrin signaling—VEGFA—psoriasis	0.000122	0.00118	CbGpPWpGaD
Trabectedin—SRC—Rac1/Pak1/p38/MMP-2 pathway—TP53—psoriasis	0.000121	0.00116	CbGpPWpGaD
Trabectedin—Diarrhoea—Prednisone—psoriasis	0.000121	0.000425	CcSEcCtD
Trabectedin—Gastrointestinal pain—Methotrexate—psoriasis	0.000121	0.000425	CcSEcCtD
Trabectedin—Nausea—Betamethasone—psoriasis	0.000121	0.000424	CcSEcCtD
Trabectedin—Nausea—Dexamethasone—psoriasis	0.000121	0.000424	CcSEcCtD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—NFKBIA—psoriasis	0.00012	0.00115	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism of lipids and lipoproteins—CARM1—psoriasis	0.000118	0.00113	CbGpPWpGaD
Trabectedin—Dizziness—Prednisone—psoriasis	0.000117	0.000411	CcSEcCtD
Trabectedin—Body temperature increased—Methotrexate—psoriasis	0.000117	0.000411	CcSEcCtD
Trabectedin—Abdominal pain—Methotrexate—psoriasis	0.000117	0.000411	CcSEcCtD
Trabectedin—PTGS1—Selenium Micronutrient Network—TNF—psoriasis	0.000116	0.00112	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—ITGAL—psoriasis	0.000116	0.00111	CbGpPWpGaD
Trabectedin—Vomiting—Prednisone—psoriasis	0.000113	0.000395	CcSEcCtD
Trabectedin—SRC—Downstream signal transduction—TYK2—psoriasis	0.000113	0.00108	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR—TYK2—psoriasis	0.000112	0.00108	CbGpPWpGaD
Trabectedin—Rash—Prednisone—psoriasis	0.000112	0.000392	CcSEcCtD
Trabectedin—Dermatitis—Prednisone—psoriasis	0.000112	0.000391	CcSEcCtD
Trabectedin—SRC—PDGFR-beta signaling pathway—JUN—psoriasis	0.000112	0.00107	CbGpPWpGaD
Trabectedin—SRC—Signaling by ERBB2—TYK2—psoriasis	0.000111	0.00107	CbGpPWpGaD
Trabectedin—Headache—Prednisone—psoriasis	0.000111	0.000389	CcSEcCtD
Trabectedin—SRC—ErbB1 downstream signaling—STAT3—psoriasis	0.000111	0.00107	CbGpPWpGaD
Trabectedin—SRC—VEGFA-VEGFR2 Pathway—VEGFA—psoriasis	0.00011	0.00106	CbGpPWpGaD
Trabectedin—SRC—NCAM signaling for neurite out-growth—IL6—psoriasis	0.00011	0.00105	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—IFIH1—psoriasis	0.00011	0.00105	CbGpPWpGaD
Trabectedin—Hypersensitivity—Methotrexate—psoriasis	0.000109	0.000383	CcSEcCtD
Trabectedin—SRC—Adaptive Immune System—REL—psoriasis	0.000108	0.00104	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—CYP2S1—psoriasis	0.000108	0.00103	CbGpPWpGaD
Trabectedin—SRC—TGF-beta Signaling Pathway—JUN—psoriasis	0.000107	0.00103	CbGpPWpGaD
Trabectedin—Asthenia—Methotrexate—psoriasis	0.000106	0.000373	CcSEcCtD
Trabectedin—SRC—Immune System—ERAP1—psoriasis	0.000105	0.00101	CbGpPWpGaD
Trabectedin—Nausea—Prednisone—psoriasis	0.000105	0.000369	CcSEcCtD
Trabectedin—SRC—Signaling by FGFR in disease—TYK2—psoriasis	0.000104	0.001	CbGpPWpGaD
Trabectedin—SRC—Signaling by VEGF—VEGFA—psoriasis	0.000104	0.001	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—HLA-C—psoriasis	0.000104	0.000997	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR—TYK2—psoriasis	0.000103	0.000993	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways in Glioblastoma—TP53—psoriasis	0.000103	0.000991	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—TNFAIP3—psoriasis	0.000103	0.000985	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR in Cancer—TYK2—psoriasis	0.000102	0.000984	CbGpPWpGaD
Trabectedin—SRC—Signaling by PDGF—TYK2—psoriasis	0.000102	0.00098	CbGpPWpGaD
Trabectedin—Diarrhoea—Methotrexate—psoriasis	0.000101	0.000355	CcSEcCtD
Trabectedin—SRC—Adaptive Immune System—HLA-C—psoriasis	9.97e-05	0.000958	CbGpPWpGaD
Trabectedin—SRC—BDNF signaling pathway—JUN—psoriasis	9.96e-05	0.000957	CbGpPWpGaD
Trabectedin—Dizziness—Methotrexate—psoriasis	9.79e-05	0.000343	CcSEcCtD
Trabectedin—SRC—PDGFR-beta signaling pathway—STAT3—psoriasis	9.65e-05	0.000927	CbGpPWpGaD
Trabectedin—SRC—BDNF signaling pathway—NFKB1—psoriasis	9.59e-05	0.000921	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—HCAR2—psoriasis	9.48e-05	0.00091	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—NDUFA5—psoriasis	9.47e-05	0.00091	CbGpPWpGaD
Trabectedin—Vomiting—Methotrexate—psoriasis	9.41e-05	0.00033	CcSEcCtD
Trabectedin—PTGS1—Selenium Micronutrient Network—IL6—psoriasis	9.38e-05	0.000901	CbGpPWpGaD
Trabectedin—Rash—Methotrexate—psoriasis	9.34e-05	0.000327	CcSEcCtD
Trabectedin—Dermatitis—Methotrexate—psoriasis	9.33e-05	0.000327	CcSEcCtD
Trabectedin—Headache—Methotrexate—psoriasis	9.28e-05	0.000325	CcSEcCtD
Trabectedin—SRC—Immune System—DDX58—psoriasis	9.27e-05	0.00089	CbGpPWpGaD
Trabectedin—SRC—NGF signalling via TRKA from the plasma membrane—TYK2—psoriasis	9.24e-05	0.000888	CbGpPWpGaD
Trabectedin—SRC—EGF/EGFR Signaling Pathway—JUN—psoriasis	9.07e-05	0.000871	CbGpPWpGaD
Trabectedin—Nausea—Methotrexate—psoriasis	8.79e-05	0.000308	CcSEcCtD
Trabectedin—SRC—Signaling by SCF-KIT—STAT3—psoriasis	8.76e-05	0.000842	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—NFKBIA—psoriasis	8.68e-05	0.000833	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—HLA-E—psoriasis	8.62e-05	0.000828	CbGpPWpGaD
Trabectedin—SRC—BDNF signaling pathway—STAT3—psoriasis	8.62e-05	0.000828	CbGpPWpGaD
Trabectedin—SRC—Senescence and Autophagy in Cancer—TP53—psoriasis	8.47e-05	0.000813	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—HLA-E—psoriasis	8.27e-05	0.000795	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—TAGAP—psoriasis	8.22e-05	0.000789	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—CYP2S1—psoriasis	8.05e-05	0.000773	CbGpPWpGaD
Trabectedin—SRC—Focal Adhesion—JUN—psoriasis	7.98e-05	0.000766	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—JUN—psoriasis	7.95e-05	0.000763	CbGpPWpGaD
Trabectedin—SRC—Downstream signal transduction—STAT3—psoriasis	7.88e-05	0.000757	CbGpPWpGaD
Trabectedin—SRC—EGF/EGFR Signaling Pathway—STAT3—psoriasis	7.84e-05	0.000753	CbGpPWpGaD
Trabectedin—SRC—Senescence and Autophagy in Cancer—IL6—psoriasis	7.75e-05	0.000744	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—NFKB1—psoriasis	7.65e-05	0.000735	CbGpPWpGaD
Trabectedin—SRC—VEGFA-VEGFR2 Pathway—IL6—psoriasis	7.63e-05	0.000733	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—NDUFA5—psoriasis	7.31e-05	0.000702	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR in disease—STAT3—psoriasis	7.31e-05	0.000702	CbGpPWpGaD
Trabectedin—SRC—Signaling by VEGF—IL6—psoriasis	7.2e-05	0.000692	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—SOCS1—psoriasis	7.2e-05	0.000691	CbGpPWpGaD
Trabectedin—SRC—Signaling by PDGF—STAT3—psoriasis	7.14e-05	0.000686	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—TYK2—psoriasis	7.11e-05	0.000683	CbGpPWpGaD
Trabectedin—SRC—TGF-beta Signaling Pathway—TP53—psoriasis	7.05e-05	0.000677	CbGpPWpGaD
Trabectedin—SRC—Immune System—ITGAL—psoriasis	7.03e-05	0.000675	CbGpPWpGaD
Trabectedin—SRC—Focal Adhesion—VEGFA—psoriasis	6.97e-05	0.00067	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—VEGFA—psoriasis	6.94e-05	0.000667	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—SOCS1—psoriasis	6.91e-05	0.000664	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—CARM1—psoriasis	6.81e-05	0.000654	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—NDUFA5—psoriasis	6.72e-05	0.000645	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—NDUFA5—psoriasis	6.66e-05	0.00064	CbGpPWpGaD
Trabectedin—SRC—Immune System—REL—psoriasis	6.57e-05	0.000631	CbGpPWpGaD
Trabectedin—SRC—NGF signalling via TRKA from the plasma membrane—STAT3—psoriasis	6.47e-05	0.000621	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—TYK2—psoriasis	6.43e-05	0.000618	CbGpPWpGaD
Trabectedin—SRC—Immune System—IFIH1—psoriasis	6.38e-05	0.000613	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—CYP2S1—psoriasis	6.21e-05	0.000597	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	6.21e-05	0.000597	CbGpPWpGaD
Trabectedin—SRC—Platelet activation, signaling and aggregation—VEGFA—psoriasis	6.18e-05	0.000593	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—HLA-B—psoriasis	6.14e-05	0.00059	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—CD8A—psoriasis	6.13e-05	0.000589	CbGpPWpGaD
Trabectedin—SRC—Signaling by SCF-KIT—IL6—psoriasis	6.12e-05	0.000588	CbGpPWpGaD
Trabectedin—SRC—Immune System—HLA-C—psoriasis	6.05e-05	0.000581	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—LEP—psoriasis	6.01e-05	0.000578	CbGpPWpGaD
Trabectedin—SRC—Immune System—TNFAIP3—psoriasis	5.97e-05	0.000574	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—TNF—psoriasis	5.95e-05	0.000571	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—HLA-B—psoriasis	5.9e-05	0.000566	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—CYP2S1—psoriasis	5.71e-05	0.000549	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—CYP2S1—psoriasis	5.66e-05	0.000544	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism of lipids and lipoproteins—APOE—psoriasis	5.65e-05	0.000542	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—NFKB1—psoriasis	5.54e-05	0.000532	CbGpPWpGaD
Trabectedin—SRC—Downstream signal transduction—IL6—psoriasis	5.5e-05	0.000529	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—NOS2—psoriasis	5.5e-05	0.000528	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR—IL6—psoriasis	5.48e-05	0.000526	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—HLA-A—psoriasis	5.46e-05	0.000525	CbGpPWpGaD
Trabectedin—SRC—Signaling by ERBB2—IL6—psoriasis	5.45e-05	0.000524	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—CRP—psoriasis	5.43e-05	0.000521	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—CARM1—psoriasis	5.26e-05	0.000505	CbGpPWpGaD
Trabectedin—SRC—Integrated Pancreatic Cancer Pathway—TP53—psoriasis	5.25e-05	0.000504	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—PPARG—psoriasis	5.24e-05	0.000503	CbGpPWpGaD
Trabectedin—SRC—Signaling by FGFR in disease—IL6—psoriasis	5.1e-05	0.00049	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR—IL6—psoriasis	5.06e-05	0.000486	CbGpPWpGaD
Trabectedin—SRC—Immune System—HLA-E—psoriasis	5.02e-05	0.000482	CbGpPWpGaD
Trabectedin—SRC—Signaling by EGFR in Cancer—IL6—psoriasis	5.01e-05	0.000481	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—HLA-DRB1—psoriasis	4.99e-05	0.000479	CbGpPWpGaD
Trabectedin—SRC—Signaling by PDGF—IL6—psoriasis	4.99e-05	0.000479	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—STAT3—psoriasis	4.98e-05	0.000478	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—NFKBIA—psoriasis	4.95e-05	0.000475	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CCL20—psoriasis	4.92e-05	0.000473	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism of lipids and lipoproteins—PPARG—psoriasis	4.92e-05	0.000472	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—ICAM1—psoriasis	4.79e-05	0.00046	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—NFKBIA—psoriasis	4.75e-05	0.000457	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—TYK2—psoriasis	4.59e-05	0.000441	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—VEGFA—psoriasis	4.55e-05	0.000437	CbGpPWpGaD
Trabectedin—SRC—NGF signalling via TRKA from the plasma membrane—IL6—psoriasis	4.52e-05	0.000434	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—NDUFA5—psoriasis	4.39e-05	0.000422	CbGpPWpGaD
Trabectedin—SRC—Immune System—SOCS1—psoriasis	4.19e-05	0.000403	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—TYK2—psoriasis	4.05e-05	0.000389	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—CARM1—psoriasis	3.93e-05	0.000378	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—CYP2S1—psoriasis	3.74e-05	0.000359	CbGpPWpGaD
Trabectedin—SRC—Immune System—CD8A—psoriasis	3.72e-05	0.000357	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—CD4—psoriasis	3.67e-05	0.000352	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—NFKB1—psoriasis	3.58e-05	0.000344	CbGpPWpGaD
Trabectedin—SRC—Immune System—HLA-B—psoriasis	3.58e-05	0.000344	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—CD4—psoriasis	3.52e-05	0.000338	CbGpPWpGaD
Trabectedin—SRC—Signaling by NGF—IL6—psoriasis	3.48e-05	0.000334	CbGpPWpGaD
Trabectedin—SRC—Immune System—HLA-A—psoriasis	3.31e-05	0.000318	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—JUN—psoriasis	3.28e-05	0.000315	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—APOE—psoriasis	3.26e-05	0.000313	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—VEGFA—psoriasis	3.25e-05	0.000312	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—CAT—psoriasis	3.24e-05	0.000311	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—STAT3—psoriasis	3.21e-05	0.000309	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—VEGFA—psoriasis	3.18e-05	0.000306	CbGpPWpGaD
Trabectedin—SRC—Immune System—CRP—psoriasis	3.16e-05	0.000304	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—NFKB1—psoriasis	3.16e-05	0.000303	CbGpPWpGaD
Trabectedin—SRC—Axon guidance—IL6—psoriasis	3.15e-05	0.000302	CbGpPWpGaD
Trabectedin—SRC—Disease—HLA-A—psoriasis	3.06e-05	0.000294	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—CARM1—psoriasis	3.03e-05	0.000291	CbGpPWpGaD
Trabectedin—SRC—Adaptive Immune System—NFKB1—psoriasis	3.03e-05	0.000291	CbGpPWpGaD
Trabectedin—SRC—Immune System—HLA-DRB1—psoriasis	3.03e-05	0.000291	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	2.97e-05	0.000285	CbGpPWpGaD
Trabectedin—SRC—Immune System—ICAM1—psoriasis	2.91e-05	0.000279	CbGpPWpGaD
Trabectedin—SRC—Immune System—NFKBIA—psoriasis	2.88e-05	0.000277	CbGpPWpGaD
Trabectedin—SRC—Disease—APOE—psoriasis	2.86e-05	0.000274	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.84e-05	0.000272	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—CARM1—psoriasis	2.79e-05	0.000268	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—TNF—psoriasis	2.78e-05	0.000267	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—CARM1—psoriasis	2.77e-05	0.000266	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—SOCS1—psoriasis	2.71e-05	0.00026	CbGpPWpGaD
Trabectedin—SRC—Disease—NOS2—psoriasis	2.66e-05	0.000256	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	2.59e-05	0.000248	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—APOE—psoriasis	2.51e-05	0.000242	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—CAT—psoriasis	2.42e-05	0.000232	CbGpPWpGaD
Trabectedin—SRC—Hemostasis—TP53—psoriasis	2.41e-05	0.000231	CbGpPWpGaD
Trabectedin—SRC—Immune System—TYK2—psoriasis	2.36e-05	0.000227	CbGpPWpGaD
Trabectedin—SRC—Developmental Biology—IL6—psoriasis	2.24e-05	0.000216	CbGpPWpGaD
Trabectedin—SRC—Immune System—IFNG—psoriasis	2.21e-05	0.000212	CbGpPWpGaD
Trabectedin—PTGS1—Metabolism—PPARG—psoriasis	2.19e-05	0.00021	CbGpPWpGaD
Trabectedin—SRC—Disease—TYK2—psoriasis	2.18e-05	0.000209	CbGpPWpGaD
Trabectedin—SRC—Immune System—CD4—psoriasis	2.14e-05	0.000205	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—LEP—psoriasis	2e-05	0.000192	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—APOE—psoriasis	2e-05	0.000192	CbGpPWpGaD
Trabectedin—SRC—Innate Immune System—IL6—psoriasis	1.98e-05	0.00019	CbGpPWpGaD
Trabectedin—SRC—Disease—CD4—psoriasis	1.97e-05	0.000189	CbGpPWpGaD
Trabectedin—SRC—Immune System—JUN—psoriasis	1.91e-05	0.000184	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—APOE—psoriasis	1.88e-05	0.000181	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—CAT—psoriasis	1.87e-05	0.000179	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—NFKBIA—psoriasis	1.86e-05	0.000179	CbGpPWpGaD
Trabectedin—SRC—Immune System—NFKB1—psoriasis	1.84e-05	0.000177	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—CARM1—psoriasis	1.82e-05	0.000175	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—CAT—psoriasis	1.72e-05	0.000165	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—CAT—psoriasis	1.7e-05	0.000163	CbGpPWpGaD
Trabectedin—SRC—Immune System—STAT3—psoriasis	1.65e-05	0.000159	CbGpPWpGaD
Trabectedin—CYP2E1—Metabolism—PPARG—psoriasis	1.64e-05	0.000157	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—TYK2—psoriasis	1.53e-05	0.000147	CbGpPWpGaD
Trabectedin—SRC—Disease—STAT3—psoriasis	1.53e-05	0.000147	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—APOE—psoriasis	1.45e-05	0.000139	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—APOE—psoriasis	1.33e-05	0.000128	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—CXCL8—psoriasis	1.33e-05	0.000128	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—APOE—psoriasis	1.32e-05	0.000127	CbGpPWpGaD
Trabectedin—CYP2C19—Metabolism—PPARG—psoriasis	1.26e-05	0.000121	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—JUN—psoriasis	1.24e-05	0.000119	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—NFKB1—psoriasis	1.19e-05	0.000114	CbGpPWpGaD
Trabectedin—CYP2D6—Metabolism—PPARG—psoriasis	1.16e-05	0.000112	CbGpPWpGaD
Trabectedin—SRC—Immune System—IL6—psoriasis	1.15e-05	0.000111	CbGpPWpGaD
Trabectedin—CYP2C9—Metabolism—PPARG—psoriasis	1.15e-05	0.000111	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—CAT—psoriasis	1.12e-05	0.000108	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—VEGFA—psoriasis	1.08e-05	0.000104	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—STAT3—psoriasis	1.07e-05	0.000103	CbGpPWpGaD
Trabectedin—SRC—Disease—IL6—psoriasis	1.07e-05	0.000102	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—APOE—psoriasis	8.72e-06	8.37e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—TP53—psoriasis	8.16e-06	7.83e-05	CbGpPWpGaD
Trabectedin—CYP3A4—Metabolism—PPARG—psoriasis	7.59e-06	7.29e-05	CbGpPWpGaD
Trabectedin—SRC—Signaling Pathways—IL6—psoriasis	7.47e-06	7.17e-05	CbGpPWpGaD
